SEC Form 4 · accession 0001676568-16-000002
ARGOS THERAPEUTICS INC · ARGS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Igor Krol
Director
Period of report
Jun 10, 2016
Accepted (ET)
Jun 14, 2016 · 4:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001105533
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $7.41 | Jun 10, 2016 | P | 11,000 | A | — | Jun 9, 2026 | Common Stock | 11,000 | 11,000 | D |
Explanation of responses
- F1This option was granted on June 10, 2016 and vest in equal amounts quarterly over the next three years.